Targeting the tumour stroma: Phenomic AI launches with $6m seed financing

Using its AI/ML platform, Phenomic has discovered antibody drugs that target the tumour stroma, which has prevented immunotherapies, such as checkpoint inhibitors, working effectively in solid cancers. Credit: Phenomic AI.



  • Phenomic tumour stroma
  • Phenomic tumour stroma